Program
08:00-09:00
Registration
08:50-09:00
Conference Opening & Welcome
Arvid van Oorschot | Conference Chair
09:00-10:30
Session1: What's New? IP Updates and Developments in Biotech and Biomed
09:00 - 09:30
Europe
09:30-10:00
UK
10:00-10:30
US
10:30-11:00
Coffee Break, Networking & Visit the Exhibition
11:00-12:30
Session 2: Case Study on CRISPR Gene Therapy (casgevy)
11:00-11:45
Case Study
11:45-12:30
Lessons Learned
12:30-13:30
Lunch Break, Networking & Visit the Exhibition
13:30-15:00
Session 3: Personalized Medicine
13:30-14:00
What are the Developments and Challenges of Patenting Personalized?
14:00-14:30
UK
14:30-15:00
US
15:00-15:30
Coffee Break, Networking & Visit the Exhibition
15:30-17:00
Session 4: AI in IP
15:30-16:00
Patenting AI Driven Invention in Europe and US
16:00-16:30
IP and its Role in the European AI Act?
16:30-17:00
Latests IP Related AI Tools in Biotech and Biomed
17:00-17:30
Panel Discussion / Q&A
17:30
End of Day One
08:30-09:00
Registration
09:00-10:30
Session 5: IP Commercialization
09:00-09:30
Developments in Licensing
09:30-10:00
Developments in IP Valorization
10:00-10:30
Developments in Technology Transfer
10:30-11:00
Coffee Break, Networking & Visit the Exhibition
11:00-12:30
Session 6: Europe's Unified Patent Court
11:00-11:30
Which UPC Matters Matter?
11:30-12:00
View on the System from the Industry; Pros, Cons & Alteratives
12:00-12:30
Comparison of UPC, UK and US Litigation
12:30-13:30
Lunch Break, Networking & Visit the Exhibition
13:30-15:00
Session 7: Developments in Antibody and Biosimilar Litigation
13:30-14:00
Europe
14:00-14:30
UK
14:30-15:00
US
15:00-15:30
Coffee Break, Networking & Visit the Exhibition
15:30-16:30
Session 8: Developments in Bolar and Research Exemption
15:30-16:00
Europe
16:00-16:30
US
17:10
Conference Closing
Arvid van Oorschot | Conference Chair
